FluoGuide reaches milestone with FG001 for phase III clinical supply

Copenhagen, Denmark, 8 November 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to inform that the first large scale batch for its lead product FG001 has been successfully manufactured in preparation for phase III clinical development.

The release as fetched from its publisher. fluoguide.com ↗